Corcept Therapeutics, Inc.
(NASDAQ : CORT)

( )
CORT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -1.41%57.296.5%$169.35m
CTLTCatalent, Inc. 0.26%73.722.1%$124.37m
JAZZJazz Pharmaceuticals Plc -2.18%108.782.4%$109.72m
VRXValeant Pharmaceuticals International, Inc. -3.00%18.4314.1%$108.44m
BHCBausch Health Cos., Inc. -3.00%18.430.0%$77.27m
UTHRUnited Therapeutics Corp. -0.37%118.6014.3%$70.59m
ICPTIntercept Pharmaceuticals, Inc. -1.58%45.3716.8%$61.79m
AXSMAxsome Therapeutics, Inc. 2.28%83.881.9%$53.24m
PRGOPerrigo Co. Plc -0.18%55.196.8%$49.55m
ZGNXZogenix, Inc. -5.13%27.587.5%$48.45m
MYOKMyoKardia, Inc. 1.95%94.041.8%$46.93m
PCRXPacira Biosciences, Inc. -0.17%54.1710.3%$44.80m
ARGXargenx SE 4.10%245.400.0%$42.59m
AMRNAmarin Corp. Plc -3.44%6.741.6%$40.87m
GWPHGW Pharmaceuticals Plc 2.44%129.626.2%$40.22m

Company Profile

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.